La Roche-Posay… a better life for oncology patients

La Roche-Posay’s longstanding mission is to aid people with sensitive or fragile skin, to improve their quality of life, and it has worked alongside dermatologists for more than a decade in the detection and prevention of skin cancer. La Roche-Posay is committed to advancing research into the cutaneous sideeffects of chemotherapy and radiotherapy so as to offer relief for cancer patients.

Today, billions of people across the world are affected by cancer, and while therapies are necessary, they can have noticeable effects on the body, and have a genuine impact on the patient’s quality of life. 2 in 3 cancer patients suffer from cutaneous side-effects ranging from lightsensitive or irritated skin to more severe symptoms and disorders.

In line with this mission, Prohealth, the exclusive distributors for La Roche-Posay, held a scientific evening for Specialists, Dermatologists, and other Healthcare professionals working within the field of Oncology on 20 October 2016 at Villa Arrigo.

The evening opened with an interesting and highly informative presentation on Barrier Protection under Adjuvant Chemotherapy for Breast Cancer given by Prof. Diana Lüftner from the German Society for Haematology and Medical Oncology. The talk aimed to highlight the importance of dealing with cutaneous side-effects so as to improve the quality of life of our Oncology patients.

In coordination with this event, Prohealth has also donated €3000 in La Roche-Posay products to the Sir Anthony Mamo Oncology Centre, and to the Children’s Oncology Ward at Mater Dei Hospital. These will be distributed to patients by the medical staff.